# Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer

> clinical trial · VERIFIED · 2026-08-14

Status: ACTIVE_NOT_RECRUITING · Sponsor: Orion Corporation, Orion Pharma · Condition: Prostate Cancer Metastatic

- Company: Orion Corporation, Orion Pharma
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT03436485

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.